79 results
Page 3 of 4
8-K
EX-99.1
c5xa4ew
13 Aug 21
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
7:00am
424B3
enjxt
5 Aug 21
Prospectus supplement
4:26pm
8-K
EX-10.2
zsl29fc
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
424B3
5vxtpdvw8dp 6jjer98b
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
0jl1brb9j4ba 2x
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.13
9tu056k3f vmp
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.16
vpnyzgh r413qkqgl
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.19
zfbf6gsw dsf5v3pdoi
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.13
2ayqyrl mhrc6b
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.17
2iessme
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
ff1z6h f2kh
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.16
odgu01b
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
hp3ccx5lbnvwjswja
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K
EX-99.1
o24eih8kwmxk
15 Mar 21
Public Investor Presentation Transcript
5:20pm
425
obq4cu4leg9 rkikn5
15 Mar 21
Business combination disclosure
8:20am
8-K
l3pnb
15 Mar 21
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
8:19am
10-K
ibbkt3xyouynrkt
5 Mar 21
Annual report
8:13am